Cargando…
Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF
Dietary supplements (DS) in the countries of the European Union falls within the scope of the food law. DS may, however, contain substances that are simultaneously applied in medicinal products as defined in the pharmaceutical law. The presence of such ingredients may cause problems with the product...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266288/ https://www.ncbi.nlm.nih.gov/pubmed/35805820 http://dx.doi.org/10.3390/ijerph19138161 |
_version_ | 1784743429518917632 |
---|---|
author | Wróbel, Kacper Milewska, Anna Justyna Marczak, Michał Kozłowski, Remigiusz |
author_facet | Wróbel, Kacper Milewska, Anna Justyna Marczak, Michał Kozłowski, Remigiusz |
author_sort | Wróbel, Kacper |
collection | PubMed |
description | Dietary supplements (DS) in the countries of the European Union falls within the scope of the food law. DS may, however, contain substances that are simultaneously applied in medicinal products as defined in the pharmaceutical law. The presence of such ingredients may cause problems with the product qualification. The phenomenon of applying such borderline ingredients in dietary supplements may require additional regulations, and ensuring them may be problematic. We conducted an analysis aiming to identify dishonest market practices resorted to by the producers and distributors of non-conforming dietary supplements. We examined mostly questioned DS and compared them with data from the RASFF system and registers of medicinal substances and pharmaceutical entities. The results show that some operators tend to re-notify the same products in response to the initiation of official control procedures. Products in the form of capsules or powders were the most common re-notifications within the 50–100 days. Based on the data obtained, it can be concluded that some entities are obliged to document the safety of the product or its compliance with the regulations, use the imperfection of the notification procedure, and re-notify the questioned product in order to keep it on the market despite potential non-compliance. |
format | Online Article Text |
id | pubmed-9266288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92662882022-07-09 Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF Wróbel, Kacper Milewska, Anna Justyna Marczak, Michał Kozłowski, Remigiusz Int J Environ Res Public Health Article Dietary supplements (DS) in the countries of the European Union falls within the scope of the food law. DS may, however, contain substances that are simultaneously applied in medicinal products as defined in the pharmaceutical law. The presence of such ingredients may cause problems with the product qualification. The phenomenon of applying such borderline ingredients in dietary supplements may require additional regulations, and ensuring them may be problematic. We conducted an analysis aiming to identify dishonest market practices resorted to by the producers and distributors of non-conforming dietary supplements. We examined mostly questioned DS and compared them with data from the RASFF system and registers of medicinal substances and pharmaceutical entities. The results show that some operators tend to re-notify the same products in response to the initiation of official control procedures. Products in the form of capsules or powders were the most common re-notifications within the 50–100 days. Based on the data obtained, it can be concluded that some entities are obliged to document the safety of the product or its compliance with the regulations, use the imperfection of the notification procedure, and re-notify the questioned product in order to keep it on the market despite potential non-compliance. MDPI 2022-07-03 /pmc/articles/PMC9266288/ /pubmed/35805820 http://dx.doi.org/10.3390/ijerph19138161 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wróbel, Kacper Milewska, Anna Justyna Marczak, Michał Kozłowski, Remigiusz Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF |
title | Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF |
title_full | Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF |
title_fullStr | Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF |
title_full_unstemmed | Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF |
title_short | Dietary Supplements Questioned in the Polish Notification Procedure upon the Basis of Data from the National Register of Functional Foods and the European System of the RASFF |
title_sort | dietary supplements questioned in the polish notification procedure upon the basis of data from the national register of functional foods and the european system of the rasff |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266288/ https://www.ncbi.nlm.nih.gov/pubmed/35805820 http://dx.doi.org/10.3390/ijerph19138161 |
work_keys_str_mv | AT wrobelkacper dietarysupplementsquestionedinthepolishnotificationprocedureuponthebasisofdatafromthenationalregisteroffunctionalfoodsandtheeuropeansystemoftherasff AT milewskaannajustyna dietarysupplementsquestionedinthepolishnotificationprocedureuponthebasisofdatafromthenationalregisteroffunctionalfoodsandtheeuropeansystemoftherasff AT marczakmichał dietarysupplementsquestionedinthepolishnotificationprocedureuponthebasisofdatafromthenationalregisteroffunctionalfoodsandtheeuropeansystemoftherasff AT kozłowskiremigiusz dietarysupplementsquestionedinthepolishnotificationprocedureuponthebasisofdatafromthenationalregisteroffunctionalfoodsandtheeuropeansystemoftherasff |